Risk of Major Cardiovascular Events in Patients With Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study
J Eur Acad Dermatol Venereol, 2020.
Rungapiromnan W, Mason KJ, Lunt M, McElhone K, Burden AD, Rutter MK, Warren RB, Griffiths CEM, Ashcroft DM; BADBIR Study Group.
Read publication: J Eur Acad Dermatol Venereol
Related
Characteristics of "super responders" and "super nonresponders" to first biologic monotherapy for ps...
Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Sec...
Age and biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the Br...
Contact Us
Find Us
The University of Manchester
First Floor Bright Building
Manchester Science Park
Manchester
M15 6GZ
0 Comments